Children’s International Polyposis (CHIP) study: a randomized, double-blind, placebo-controlled study of celecoxib in children with familial adenomatous polyposis

OBJECTIVE: To evaluate the efficacy and safety of celecoxib versus placebo in the prevention and treatment of colorectal polyposis in children with familial adenomatous polyposis (FAP). METHODS: In this Phase III, double-blind, randomized, placebo-controlled, multicenter trial patients aged 10–17 ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Burke, Carol A, Phillips, Robin, Berger, Manuela F, Li, Chunming, Essex, Margaret Noyes, Iorga, Dinu, Lynch, Patrick M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525455/
https://www.ncbi.nlm.nih.gov/pubmed/28765715
http://dx.doi.org/10.2147/CEG.S121841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525455/
https://www.ncbi.nlm.nih.gov/pubmed/28765715
http://dx.doi.org/10.2147/CEG.S121841

Ejemplares similares